Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2026
SLC25A3 exports mitochondrial copper to metalate cytochrome <i>c</i> oxidase and prevent cuproptosis
Mohammad Zulkifli, Ifrah Farid, Laura E Oldfather, et al.
Cell Metabolism
|
May 12, 2015
Cooperation between COA6 and SCO2 in COX2 maturation during cytochrome c oxidase assembly links two mitochondrial cardiomyopathies
David Pacheu-Grau, Bettina Bareth, Jan Dudek, et al.
Cancer Cell International
|
July 19, 2025
The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells
Tetiana Katrii, Tanya Freywald, Malkon G Estrada, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2021
Prosurvival IL-7-Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1-TCF1-Id3 and Metabolic AMPKα1-ULK1-ATG7 Pathways
Aizhang Xu, Scot C Leary, Md Fahmid Islam, et al.
Human Molecular Genetics
|
August 21, 2003
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency
Hana Antonicka, Scot C Leary, Guy-Hellen Guercin, et al.
Elife
|
February 16, 2021
Mitochondrial copper and phosphate transporter specificity was defined early in the evolution of eukaryotes
Xinyu Zhu, Aren Boulet, Katherine M Buckley, et al.
Cancer Immunology, Immunotherapy : CII
|
November 18, 2025
CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8<sup>+</sup>CD103<sup>+</sup> cDC1 and TRM cell responses
Zhaojia Wu, Zhenyu Yang, Tauqeer Iftikhar, et al.
Molecular Genetics and Metabolism
|
June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy
Scot C Leary, Andre Mattman, Timothy Wai, et al.
Human Molecular Genetics
|
July 18, 2025
Heart is the most susceptible organ in an isogenic background to loss of function mutations in the mitochondrial metallochaperone SCO1
Sampurna Ghosh, Kimberly A Jett, Zakery N Baker, et al.
The Journal of Biological Chemistry
|
January 18, 2002
Chronic treatment with azide in situ leads to an irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation
Scot C Leary, Bruce C Hill, Carrie N Lyons, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2026
SLC25A3 exports mitochondrial copper to metalate cytochrome <i>c</i> oxidase and prevent cuproptosis
Mohammad Zulkifli, Ifrah Farid, Laura E Oldfather, et al.
Cell Metabolism
|
May 12, 2015
Cooperation between COA6 and SCO2 in COX2 maturation during cytochrome c oxidase assembly links two mitochondrial cardiomyopathies
David Pacheu-Grau, Bettina Bareth, Jan Dudek, et al.
Cancer Cell International
|
July 19, 2025
The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells
Tetiana Katrii, Tanya Freywald, Malkon G Estrada, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2021
Prosurvival IL-7-Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1-TCF1-Id3 and Metabolic AMPKα1-ULK1-ATG7 Pathways
Aizhang Xu, Scot C Leary, Md Fahmid Islam, et al.
Human Molecular Genetics
|
August 21, 2003
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency
Hana Antonicka, Scot C Leary, Guy-Hellen Guercin, et al.
Elife
|
February 16, 2021
Mitochondrial copper and phosphate transporter specificity was defined early in the evolution of eukaryotes
Xinyu Zhu, Aren Boulet, Katherine M Buckley, et al.
Cancer Immunology, Immunotherapy : CII
|
November 18, 2025
CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8<sup>+</sup>CD103<sup>+</sup> cDC1 and TRM cell responses
Zhaojia Wu, Zhenyu Yang, Tauqeer Iftikhar, et al.
Molecular Genetics and Metabolism
|
June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy
Scot C Leary, Andre Mattman, Timothy Wai, et al.
Human Molecular Genetics
|
July 18, 2025
Heart is the most susceptible organ in an isogenic background to loss of function mutations in the mitochondrial metallochaperone SCO1
Sampurna Ghosh, Kimberly A Jett, Zakery N Baker, et al.
The Journal of Biological Chemistry
|
January 18, 2002
Chronic treatment with azide in situ leads to an irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation
Scot C Leary, Bruce C Hill, Carrie N Lyons, et al.
Page
of 6